Literature DB >> 12800215

Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Li-Dong Wang1, Shu Zheng, Zuo-Yu Zheng, Alan G Casson.   

Abstract

Gastric cardia adenocarcinoma (GCA) is an under-studied subject. The pathogenesis, molecular changes in the early stage of carcinogenesis and related risk factors have not been well characterized. There is evidence, however, that GCA differs from cancer of the rest of the stomach in terms of natural history and histopathogenesis. Adenocarcinomas of the lower esophagus, esophagogastric junction (EGJ) and gastric cardia have been given much attention because of their increasing incidences in the past decades, which is in striking contrast with the steady decrease in distal stomach adenocarcinoma. In China, epidemiologically, GCA shares very similar geographic distribution with esophageal squamous cell carcinoma (SCC), especially in Linzhou (formerly Linxian County), Henan Province, North China, the highest incidence area of esophageal SCC in the world. Historically, both GCA and SCC in these areas were referred to as esophageal cancer (EC) by the public because of the common syndrome of dysphagia. In Western countries, Barrett's esophagus is very common and has been considered as an important precancerous lesion of adenocarcinoma at EGJ. Because of the low incidence of Barrett's esophagus in China, it is unlikely to be an important factor in early stage of EGJ adenocarcinoma development. However, Z line up-growth into lower esophagus may be one of the characteristic changes in these areas in early stage of GCA development. Whether intestinal metaplasia (IM) is a premalignant lesion for GCA is still not clear. Higher frequency of IM observed at adjacent GCA tissues in Henan suggests the possibility of IM as a precancerous lesion for GCA in these areas. Molecular information on GCA, especially in early stage, is very limited. The accumulated data about the changes of tumor suppressor gene, such as p53 mutation, and ontogeny, such as C-erbB2, especially the similar alterations in GCA and SCC in the same patient, indicated that there might be some similar risk factors, such as nitrosamine, involved in both GCA and SCC in Henan population. The present observations also suggest that GCA should be considered as a distinct entity.

Entities:  

Mesh:

Year:  2003        PMID: 12800215      PMCID: PMC4611775          DOI: 10.3748/wjg.v9.i6.1156

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  129 in total

1.  The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.

Authors:  J M Risk; H S Mills; J Garde; J R Dunn; K E Evans; M Hollstein; J K Field
Journal:  Dis Esophagus       Date:  1999       Impact factor: 3.429

2.  Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.

Authors:  H Takahashi; S Ichimiya; Y Nimura; M Watanabe; M Furusato; S Wakui; R Yatani; S Aizawa; A Nakagawara
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

Review 3.  The emerging p53 gene family.

Authors:  W G Kaelin
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

4.  Mutational analysis of p73 and p53 in human cancer cell lines.

Authors:  H Yoshikawa; M Nagashima; M A Khan; M G McMenamin; K Hagiwara; C C Harris
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

5.  Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.

Authors:  Hiroyuki Tsujimoto; Akeo Hagiwara; Hiroyuki Sugihara; Takanori Hattori; Hisakazu Yamagishi
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

6.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

Review 7.  Barrett's esophagus, dysplasia, and adenocarcinoma.

Authors:  R C Haggitt
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

8.  Relevance of N-nitrosamines to oesophageal cancer in China.

Authors:  S H Lu; S X Chui; W X Yang; X N Hu; L P Guo; F M Li
Journal:  IARC Sci Publ       Date:  1991

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

Authors:  P S White; J M Maris; C Beltinger; E Sulman; H N Marshall; M Fujimori; B A Kaufman; J A Biegel; C Allen; C Hilliard; M B Valentine; A T Look; H Enomoto; S Sakiyama; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  20 in total

1.  Variant TP53BP1 rs560191 G>C is associated with risk of gastric cardia adenocarcinoma in a Chinese Han population.

Authors:  Sheng Zhang; Weifeng Tang; Guowen Ding; Chao Liu; Ruiping Liu; Suocheng Chen; Haiyong Gu; Chunzhao Yu
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

2.  Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.

Authors:  Gui-Sheng Liu; Jun Gong; Peng Cheng; Jun Zhang; Ying Chang; Lei Qiang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Authors:  Da-Long Wu; Hui-Xing Yi; Feng-Ying Sui; Xiao-Hong Jiang; Xiao-Ming Jiang; Ying-Ying Zhao
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival.

Authors:  Susanne Bartelt; Felix Momm; Christian Weissenberger; Johannes Lutterbach
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 5.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus.

Authors:  Zdenek Kala; Jiří Dolina; Filip Marek; Lydie Izakovicova Holla
Journal:  J Hum Genet       Date:  2007-05-03       Impact factor: 3.172

Review 7.  Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis.

Authors:  Jing Wang; Hai-Feng Pan; Yun-Tao Hu; Yu Zhu; Qian He
Journal:  Dig Dis Sci       Date:  2009-09-24       Impact factor: 3.199

8.  Effect of body mass index on adenocarcinoma of gastric cardia.

Authors:  Ji Zhang; Xiang-Qian Su; Xiao-Jiang Wu; Ya-Hang Liu; Hua Wang; Xiang-Nong Zong; Yi Wang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.

Authors:  Myoung Sook Kim; Xiaofei Chang; Cynthia LeBron; Jatin K Nagpal; Juna Lee; Yiping Huang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; David Sidransky
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

10.  High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran.

Authors:  M H Derakhshan; A Yazdanbod; A R Sadjadi; B Shokoohi; K E L McColl; R Malekzadeh
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.